Will Budget 2024 Prioritize Healthcare And Pharma Needs? Time To Buy Pharma Stocks?

India's pharmaceutical industry aims to become more than $100 billion by 2030, targeting a 7% global market share. To achieve this, the industry is seeking increased government incentives to boost research and development (R&D) investments. Expectations are high for the upcoming budget to introduce measures that encourage investment in pharmaceutical research and innovation. Additionally, the healthcare sector is looking for significant focus on vaccination protocols and facilities, particularly for cervical cancer and child immunization. Will the budget bring the necessary support and attention to these critical areas? And which stocks should you focus on from the healthcare and pharma industry ahead of Budget 2024? Watch this special series form Business Today TV on Budget stocks.